Recurrent Breast Cancer
139
6
12
88
Key Insights
Highlights
Success Rate
76% trial completion
Published Results
54 trials with published results (39%)
Research Maturity
88 completed trials (63% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 74/100
20.1%
28 terminated out of 139 trials
75.9%
-10.6% vs benchmark
4%
5 trials in Phase 3/4
61%
54 of 88 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 88 completed trials
Clinical Trials (139)
Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Circulating miRNAs.
ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer
A Biomarker Screening Protocol for Participants With Solid Tumors
A Study to Investigate LYL797 in Adults With Solid Tumors
Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy
Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer
Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer
A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.
Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer
T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer
Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer
BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer
Reoperative Sentinel Lymph Node Biopsy in Patients With Recurrent Ipsilateral Breast Cancer